All News

Digital medicine is the use of technology to measure or intervene in certain health conditions and is overseen by the FDA, unlike digital health apps or technologies.

A panel of experts at the Asembia 2022 Specialty Pharmacy Summit discussed some of the obstacles in providing medications approved under Emergency Use Authorization.

Discovery has the potential to also benefit treatment choices, investigators from Georgetown Lombardi Comprehensive Cancer Center say.

Results of a meta-analysis of randomized clinical trials published in JAMA shows improvement in 6 of 8 domains.

The FDA approved daridorexant in January 2022 to treat insomnia after it showed improvements in changes in latency to persistent sleep and wake after sleep onset.

For COVID-19 to turn into an endemic, there are a few criteria that must be met.

Legislation allowing pharmacists to prescribe contraceptives is becoming more widespread.

Cytisinicline demonstrated significantly better quit rates than placebo in 6 and 12 week trials.

Vosevi is a fixed-dose combination product containing sofosbuvir, velpatasvir, and voxilaprevir for the re-treatment of adults with chronic hepatitis C.

Quiz questions to assess your knowledge on common symptoms and treatments for Lyme disease.

On the Shelf is hosted by Joanna Lewis and features conversations about wellness including nutrition, supplements, skin care, and anything else that is over-the-counter.

Four examples of patient care services that pharmacies can implement and why they can be beneficial to a pharmacy’s business model.

Study shows high-dose vitamin D, omega-3s, and a simple home strength exercise program led to a cumulative reduction in cancer risk by 61% in healthy adults 70 years of age and older.

Tracy Russell, senior director of State Government Affairs at CoverMyMeds, discusses how the role of the pharmacist in the specialty pharmacy space has expanded during the COVID-19 pandemic.

Data show that 89% of individuals treated for persistent AFiB remained symptom-free for up to 15 months after using the product.

Study shows that the vaccine candidate demonstrated superior neutralizing antibody titers over the control, Vaxzevria from AstraZeneca.

Clinical trial participants who took the drug lost up to 52 lb., or 24 kg, in the 72-week, phase 3 study.

Not only is burnout impacting pharmacists, but it also has unacceptable impacts on patients.

The APhA noted that burnout had been a problem in the pharmacy profession for a long time but had been exacerbated by the COVID-19 pandemic.

Patients want more out of community pharmacies in a post-pandemic culture.

Tizlelizumab is a unique anti-PD-1 monoclonal antibody that is being analyzed in 14 pivotal clinical trials across an array of solid tumors.

Omidubicel is a first-in-class, advanced nicotinamide-enabled stem cell therapy candidate being evaluated as the first potential allogeneic advanced cell therapy donor source for individuals with blood cancers in need of a transplant.

Educating patients can be especially rewarding with children.

FDA approves 15 mg upadacitinib (Rinvoq; AbbVie) for the treatment of adult patients with active ankylosing spondylitis who previously showed an inadequate response or intolerance to 1 or more tumor necrosis factor inhibitors.

Viloxazine extended-release capsules are indicated as a once-daily, flexible-dose nonstimulant drug for attention-deficit hyperactivity disorder.

Osteseconazole (Vivjoa) is the first FDA-approved treatment for recurrent vulvovaginal candidiasis, also known as chronic yeast infection, in women with a history of the condition who are not of reproductive potential.

Ertugliflozin (Steglatro) is a sodium glucose co-transporter 2 inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Nonprescription migraine pain reliever combines acetaminophen, aspirin, and caffeine to relieve migraine pain.

Students from the University of the Sciences’ Philadelphia College of Pharmacy triumphed.